Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Substance Use Disorder Update 2022

Amanda Simonton, Ph.D., APRN, PMHNP-BC
Clinical Assistant Professor
The University of Texas at Austin School of Nursing

Learning Objectives 
  • Describe updates to prevalence rates in SUDs and overdose death rates
  • Review medications available for SUDs and possible future treatment options
  • Discuss the buprenorphine waiver, how the waiver is obtained, and the waiver exemption

This program consists of one video and downloadable resources in PDF format.
To begin, scroll to the bottom of this page and click the green "Purchase Now" button. You will then be asked to log in or create an account. If you have taken a course with UT Pharmacy CE previously, be sure to use the same login as before. Once you are logged in, you can complete the registration and then take the course. After you have registered, you will be able to access this course at any time until the expiration date. 
Speaker information and disclosures can be found in the tab below.   



CE Hours


CE Units


Activity Type

  • Knowledge


Continuing Education Credit
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.10 CEUs (1.00 contact hour) of continuing education credit. To receive 1.00 contact hour of CE credit, the participant must watch the included video in its entirety, pass the online post-test ( >70% within 5 attempts), and complete the online evaluation. Upon successfully completing the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3-7 days).




Substance Use Disorder Update
About the Speaker
Amanda Simonton, Ph.D., APRN, PMHNP-BC
Clinical Assistant Professor
The University of Texas at Austin School of Nursing

Amanda J. Simonton, PhD, APRN, PMHNP-BC is a Clinical Assistant Professor at the University of Texas at Austin School of Nursing and a Psychiatric Mental Health Nurse Practitioner at the Texas Child Study Center at Dell Children’s Medical Center. She has been a Registered Nurse since 2013 and previously worked in the Intermediate Care Unit at Seton Medical Center Austin and the Psychiatric Emergency Department at University Medical Center Brackenridge. As a psychiatric nurse practitioner, she has primarily worked with adults with dual-diagnosed (substance use and mental health) disorders and with children and adolescents. She earned her Bachelor of Science in Nursing (’13), Master of Science in Nursing (’18), and Doctor of Philosophy (’20) through the School of Nursing at the University of Texas at Austin. She is active in presenting at the annual conferences for Texas Nurse Practitioners and the American Psychiatric Nurses Association. She is currently on the Policy Council for Texas Nurse Practitioners and the President-Elect on the American Psychiatric Nurses Association Texas Chapter Board of Directors. Dr. Simonton is also a member of two steering committees, which focus on the treatment of schizophrenia spectrum disorders and bipolar depression, for Medscape Inc. Her research and clinical interests are to improve the lives of individuals with substance use disorders and serious mental illness by utilizing evidence-based care and best practices in the field of psychiatry and psychology.

Disclosure: Dr. Simonton has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

–Medscape Inc. (ongoing)
–Takeda Pharmaceuticals (completed 9/2022)
–Alkermes Inc (completed 9/2021)
Corium Inc (completed 7/2021)
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.


Activity Number


Release Date: Oct 13, 2022
Credit Expiration Date: Oct 12, 2025

CE Hours